The Federal Trade Commission, jointly with the Department of Justice and the U.S. Food and Drug Administration, have sued a New York-based marketer of herbal tea, seeking to permanently block deceptive ads that claim its Earth Tea is clinically proven to treat, cure, and prevent COVID-19. The FTC also is seeking to impose civil penalties on the defendants behind Earth Tea under the COVID-19 Consumer Protection Act.
The complaint announced today names as defendants Brooklyn-based B4B Earth Tea LLC, B4B Corp., and its owner, Andrew Martin (“Busta”) Sinclair.
“Without any scientific evidence, the defendants claimed that drinking their herbal tea is more effective in preventing COVID-19 than approved vaccines, and cures anyone who has gotten ill within 24 hours,” said Samuel Levine, Director of the FTC’s Bureau of Consumer Protection. “In bringing this matter with our partners at the Department of Justice and the Food and Drug Administration, the Commission continues its commitment to using every tool available to stop and deter those who would treat the pandemic as opportunity to peddle bogus treatments.”
“The Department of Justice will not tolerate individuals or companies seeking to profit from the COVID-19 public health emergency by unlawfully advertising unproven products,” said Principal Deputy Assistant Attorney General Brian M. Boynton, head of the Department of Justice’s Civil Division. “The Department is committed to protecting consumers and enforcing the COVID-19...
Read Full Story:
https://www.ftc.gov/news-events/press-releases/2022/03/ftc-doj-fda-take-actio...